Ilker Yalcin

3.6k total citations · 1 hit paper
28 papers, 2.7k citations indexed

About

Ilker Yalcin is a scholar working on Rheumatology, Surgery and Urology. According to data from OpenAlex, Ilker Yalcin has authored 28 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 15 papers in Surgery and 14 papers in Urology. Recurrent topics in Ilker Yalcin's work include Pelvic floor disorders treatments (23 papers), Anorectal Disease Treatments and Outcomes (14 papers) and Urinary Bladder and Prostate Research (14 papers). Ilker Yalcin is often cited by papers focused on Pelvic floor disorders treatments (23 papers), Anorectal Disease Treatments and Outcomes (14 papers) and Urinary Bladder and Prostate Research (14 papers). Ilker Yalcin collaborates with scholars based in United States, United Kingdom and Canada. Ilker Yalcin's co-authors include Richard C. Bump, Norman R. Zinner, Peggy Norton, Donald L. Patrick, Don P. Buesching, Donald M. Bushnell, Todd H. Wagner, Mona L. Martin, Lars Viktrup and John H. Heiligenstein and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Obstetrics and Gynecology and The Journal of Urology.

In The Last Decade

Ilker Yalcin

27 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of two global impression questionnaires for incontinence

2003 697 citations Ilker Yalcin, Richard C. Bump American Journal of Obstetrics and Gynecology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilker Yalcin United States	20	2.1k	1.4k	1.2k	804	336	28	2.7k
Christine L. Thompson United States	18	1.6k 0.8×	1.8k 1.3×	385 0.3×	966 1.2×	331 1.0×	23	2.5k
Judith D. Bentkover United States	14	1.0k 0.5×	943 0.7×	255 0.2×	628 0.8×	76 0.2×	25	1.6k
Hashim Hashim United Kingdom	24	1.7k 0.8×	2.1k 1.6×	502 0.4×	888 1.1×	125 0.4×	154	2.6k
Vik Khullar United Kingdom	33	4.3k 2.1×	3.8k 2.8×	1.6k 1.4×	2.2k 2.7×	281 0.8×	161	5.3k
Marion Kvasz United States	11	827 0.4×	653 0.5×	316 0.3×	466 0.6×	39 0.1×	17	1.4k
Chaitanya Sarawate United States	12	232 0.1×	47 0.0×	410 0.4×	92 0.1×	467 1.4×	14	1.4k
Pierre Pfitzenmeyer France	22	125 0.1×	45 0.0×	144 0.1×	246 0.3×	371 1.1×	81	1.4k
Mehool Patel United Kingdom	10	129 0.1×	83 0.1×	69 0.1×	467 0.6×	293 0.9×	19	932
James Bernard Walsh Ireland	18	116 0.1×	96 0.1×	125 0.1×	141 0.2×	207 0.6×	41	983
H. Keïta France	20	99 0.0×	82 0.1×	577 0.5×	140 0.2×	32 0.1×	57	1.8k

Countries citing papers authored by Ilker Yalcin

Since Specialization

Citations

This map shows the geographic impact of Ilker Yalcin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilker Yalcin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilker Yalcin more than expected).

Fields of papers citing papers by Ilker Yalcin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilker Yalcin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilker Yalcin. The network helps show where Ilker Yalcin may publish in the future.

Co-authorship network of co-authors of Ilker Yalcin

This figure shows the co-authorship network connecting the top 25 collaborators of Ilker Yalcin. A scholar is included among the top collaborators of Ilker Yalcin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilker Yalcin. Ilker Yalcin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolfe, Cameron R., Jonathan Cohen, Anna Holmes, et al.. (2025). Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY). Clinical Infectious Diseases. 81(3). 439–450. 1 indexed citations

Ison, Michael G., Debra F. Weinstein, Anna Holmes, et al.. (2023). Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE). Open Forum Infectious Diseases. 10(7). ofad314–ofad314. 7 indexed citations

Tarcan, Tufan, et al.. (2014). Safety and Efficacy of Retropubic or Transobturator Midurethral Slings in a Randomized Cohort of Turkish Women. Urologia Internationalis. 93(4). 449–453. 6 indexed citations

Yalcin, Ilker & Lars Viktrup. (2007). Comparison of physician and patient assessments of incontinence severity and improvement. International Urogynecology Journal. 18(11). 1291–1295. 29 indexed citations

Steers, William D., Sender Herschorn, Karl J. Kreder, et al.. (2007). Duloxetine compared with placebo for treating women with symptoms of overactive bladder. British Journal of Urology. 100(2). 337–345. 96 indexed citations

Bent, Alfred E., Angelo E. Gousse, Carl G. Klutke, et al.. (2007). Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourology and Urodynamics. 27(3). 212–221. 36 indexed citations

Yalcin, Ilker, Donald L. Patrick, Kent H. Summers, Kraig Kinchen, & Richard C. Bump. (2006). Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence. Urology. 67(6). 1304–1308. 48 indexed citations

Castro‐Díaz, David, Paulo César Rodrigues Palma, Céline Bouchard, et al.. (2006). Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence. International Urogynecology Journal. 18(8). 919–929. 25 indexed citations

Viktrup, Lars & Ilker Yalcin. (2006). Duloxetine treatment of stress urinary incontinence in women: Effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 133(1). 105–113. 19 indexed citations

10.

Wernicke, Joachim, et al.. (2006). A retrospective pooled analysis of duloxetine safety in 23 983 subjects. Current Medical Research and Opinion. 23(1). 175–184. 83 indexed citations

11.

Ghoniem, Gamal M., Jules Schagen van Leeuwen, Denise M. Elser, et al.. (2005). A RANDOMIZED CONTROLLED TRIAL OF DULOXETINE ALONE, PELVIC FLOOR MUSCLE TRAINING ALONE, COMBINED TREATMENT AND NO ACTIVE TREATMENT IN WOMEN WITH STRESS URINARY INCONTINENCE. The Journal of Urology. 173(5). 1647–1653. 120 indexed citations

12.

Bent, Alfred E., Angelo E. Gousse, Susan L. Hendrix, et al.. (2005). Validation of a Two-Item Quantitative Questionnaire for the Triage of Women With Urinary Incontinence. Obstetrics and Gynecology. 106(4). 767–773. 20 indexed citations

13.

Wernicke, Joachim, et al.. (2005). Safety and adverse event profile of duloxetine. Expert Opinion on Drug Safety. 4(6). 987–993. 47 indexed citations

14.

Yalcin, Ilker & Richard C. Bump. (2004). The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. American Journal of Obstetrics and Gynecology. 191(1). 194–197. 31 indexed citations

15.

Bump, Richard C., et al.. (2004). Oral Poster 60: Biomechanical and Electrophysiological Effects of Duloxetine in Women with Stress Urinary Incontinence. Journal of Pelvic Medicine and Surgery. 10. S37–S38. 2 indexed citations

16.

Dmochowski, Roger R., John R. Miklos, Peggy Norton, et al.. (2003). Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence. The Journal of Urology. 170(4 Part 1). 1259–1263. 212 indexed citations

17.

Yalcin, Ilker & Richard C. Bump. (2003). Validation of two global impression questionnaires for incontinence. American Journal of Obstetrics and Gynecology. 189(1). 98–101. 697 indexed citations breakdown →

18.

Norton, Peggy, Norman R. Zinner, Ilker Yalcin, & Richard C. Bump. (2002). Duloxetine versus placebo in the treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology. 187(1). 40–48. 240 indexed citations

19.

Faries, Douglas E., et al.. (2001). Validation of the ADHD Rating Scale as a clirlician administered and scored instrument. Journal of Attention Disorders. 5(2). 107–115. 162 indexed citations

20.

Patrick, Donald L., Mona L. Martin, Donald M. Bushnell, et al.. (1999). Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology. 53(1). 71–76. 414 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact